These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 33307314)
1. Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis. Sangiovanni S; Morales EI; Fernández-Trujillo L Respir Med; 2021 Jan; 176():106283. PubMed ID: 33307314 [TBL] [Abstract][Full Text] [Related]
2. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Bilton D; Henig N; Morrissey B; Gotfried M Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030 [TBL] [Abstract][Full Text] [Related]
3. The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis. Dhand R J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):121-138. PubMed ID: 29077527 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis. Yang JW; Fan LC; Lu HW; Miao XY; Mao B; Xu JF Clin Respir J; 2016 Nov; 10(6):731-739. PubMed ID: 25620629 [TBL] [Abstract][Full Text] [Related]
5. Bronchiectasis and inhaled tobramycin: A literature review. Elborn JS; Blasi F; Haworth CS; Ballmann M; Tiddens HAWM; Murris-Espin M; Chalmers JD; Cantin AM Respir Med; 2022 Feb; 192():106728. PubMed ID: 34998112 [TBL] [Abstract][Full Text] [Related]
6. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection. VanDevanter DR; Gonda I; Dahms J; Cipolla D; Davis AM; Chalmers JD; Froehlich J Clin Microbiol Infect; 2019 Dec; 25(12):1532-1538. PubMed ID: 31035017 [TBL] [Abstract][Full Text] [Related]
7. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142 [TBL] [Abstract][Full Text] [Related]
8. [Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection]. Tabernero Huguet E; Gil Alaña P; Alkiza Basañez R; Hernández Gil A; Garros Garay J; Artola Igarza JL Rev Esp Geriatr Gerontol; 2015; 50(3):111-5. PubMed ID: 25724860 [TBL] [Abstract][Full Text] [Related]
9. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials. Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review. Fjaellegaard K; Sin MD; Browatzki A; Ulrik CS Chron Respir Dis; 2017 May; 14(2):174-186. PubMed ID: 27507832 [TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis. Laska IF; Crichton ML; Shoemark A; Chalmers JD Lancet Respir Med; 2019 Oct; 7(10):855-869. PubMed ID: 31405826 [TBL] [Abstract][Full Text] [Related]
12. Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis. Orriols R; Hernando R; Ferrer A; Terradas S; Montoro B Respiration; 2015; 90(4):299-305. PubMed ID: 26340658 [TBL] [Abstract][Full Text] [Related]
13. Eradication of Blanco-Aparicio M; Saleta Canosa JL; Valiño López P; Martín Egaña MT; Vidal García I; Montero Martínez C Chron Respir Dis; 2019; 16():1479973119872513. PubMed ID: 31480862 [TBL] [Abstract][Full Text] [Related]
14. Results of Tobramycin Inhalation Therapy in Patients with Noncystic Fibrosis Bronchiectasis with Tanriverdi E; Yildirim BZ; Gul S; Chousein EGU; Turan D; Çınarka H; Özgül MA; Cetinkaya E J Aerosol Med Pulm Drug Deliv; 2021 Sep; 34(5):274-279. PubMed ID: 33351705 [No Abstract] [Full Text] [Related]
15. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis. Rubin BK J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):71-6. PubMed ID: 18518833 [TBL] [Abstract][Full Text] [Related]
16. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Barker AF; Couch L; Fiel SB; Gotfried MH; Ilowite J; Meyer KC; O'Donnell A; Sahn SA; Smith LJ; Stewart JO; Abuan T; Tully H; Van Dalfsen J; Wells CD; Quan J Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):481-5. PubMed ID: 10934074 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1). Loebinger MR; Polverino E; Blasi F; Elborn SJ; Chalmers JD; Tiddens HA; Goossens H; Tunney M; Zhou W; Angyalosi G; Hill AT; Haworth CS; Pulm Pharmacol Ther; 2019 Oct; 58():101834. PubMed ID: 31433997 [TBL] [Abstract][Full Text] [Related]
18. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Inhaled Antibiotics for the Treatment of Chronic Pseudomonas aeruginosa Lung Infection in Patients With Cystic Fibrosis: Systematic Literature Review and Network Meta-analysis. Elborn JS; Vataire AL; Fukushima A; Aballea S; Khemiri A; Moore C; Medic G; Hemels ME Clin Ther; 2016 Oct; 38(10):2204-2226. PubMed ID: 27692977 [TBL] [Abstract][Full Text] [Related]
20. [Use of inhaled tobramycin in patients with cystic fibrosis]. Chermenskiĭ AG; Gembitskaia TE Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]